Semaglutide for managing overweight and obesity
                                Année de publication: 2023                            
                            
                                                            
                                            Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults.
Commercial availability
The Wegovy brand of semaglutide is not commercially available yet.                                        
                                                                    